3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
2
TP53 Y220C Mutation
1
Smoking
1
Rectal Neoplasms
1
Pulmonary Disease, Chronic Obstructive
1
Peripheral Nervous System Diseases
1
Meningioma
1
Medulloblastoma
1
Lymphoma, Mantle-Cell
1
Localized Prostate Cancer
1
Leukemia, Myeloid, Acute
1
Head and Neck Neoplasms
1
HER2 IHC3+ Advanced Colorectal Cancer
1
Genetic Diseases, Inborn
1
Deglutition Disorders
1
Cognitive Dysfunction
1
Interventions
Echocardiography
2
empagliflozin
1
Social Determinants of Health
1
Hematologic Tests
1
Environmental Biomarkers
1
Carvedilol
1
Cardiography, Impedance
1
Blood Pressure Determination
1
(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Cardiotoxicity
×
Tablets
×
90 days
×
Clear all
No trials found.